Other news to note for July 23, 2026
AI Briefing
- Bayer announces partnership with Bioaffinity to develop new cancer treatment.
- Beckman BioScience to acquire Biolife for $2.5 billion in stock deal.
- Invitrocue partners with Ispen to develop innovative cancer diagnostic solutions.
Source Summary
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bayer, Beckman, Bioaffinity, Biolife, Cizzle, Eleo, Elephas, Evogene, Invitrocue, Ispen, Kairos, Masmec, Memo, Nanosomix, Pictor, Repligen, Trinity, Wisner.
Advertisement